BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 47 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,193,465 | +752.1% | 4,221,000 | +786.8% | 0.04% | +775.0% |
| Q3 2021 | $492,135 | -85.3% | 476,000 | -85.2% | 0.00% | -89.2% |
| Q3 2020 | $3,350,000 | +11864.3% | 3,207,000 | +13843.5% | 0.04% | – |
| Q2 2020 | $28,000 | +21.7% | 23,000 | +4.5% | 0.00% | – |
| Q1 2020 | $23,000 | -80.8% | 22,000 | -80.7% | 0.00% | -100.0% |
| Q4 2019 | $120,000 | -71.2% | 114,000 | -71.4% | 0.00% | -66.7% |
| Q2 2019 | $416,000 | -87.0% | 398,000 | -88.3% | 0.00% | -82.4% |
| Q1 2018 | $3,209,000 | -6.4% | 3,400,000 | -0.9% | 0.02% | +6.2% |
| Q4 2017 | $3,427,000 | – | 3,430,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |